Skip to main content
Live

Market Intelligence

Page 189

Stocks·ai

AI’s $650 Billion Hangover: Why Wall Street Is Suddenly Betting Against the Tech Spending Spree

Feb 7, 2026·8m
Stocks·market-breadth

S&P 500’s K-Shaped Rally: Why Market Breadth Is the Only Metric That Matters in 2026

Feb 7, 2026·8m
Stocks·big-pharma

Obesity Wars and Patent Cliffs: Big Pharma’s Earnings Blowout Masks a Brewing Storm

Feb 7, 2026·8m
Stocks·sp500-equal-weight

S&P 500 Equal Weight Index Hits All-Time High as Market Rotation Reshapes the Playbook

Feb 7, 2026·8m
Stocks·dow-jones

Dow 50,000: Why the Oldest Index Just Schooled the AI Hype Cycle

Feb 7, 2026·8m
Stocks·xlk

Tech’s Flatline: XLK’s Stagnation Signals Exhaustion as AI Hype Collides with Reality

Feb 7, 2026·8m
Stocks·sp500

Wall Street’s Growing Divide: Why Volatility Is Lurking Beneath the S&P 500’s Calm Surface

Feb 7, 2026·8m
Stocks·ai

AI Stocks Flatline as Investors Rotate to Old-Economy Plays: Is the Tech Trade Broken?

Feb 7, 2026·8m
Stocks·ai

Big Tech’s $650 Billion AI Spending Binge: Are Investors Finally Calling the Bluff?

Feb 7, 2026·8m
Stocks·pharma

Obesity Wars and Pharma’s New Arms Race: Why Healthcare Is the Market’s Silent Juggernaut

Feb 7, 2026·8m
Stocks·sp500-equal-weight

S&P 500 Equal Weight Hits All-Time High: Rotation or Mirage for Real Market Breadth?

Feb 7, 2026·8m
Stocks·dow-jones

Dow 50,000: Why the Oldest Index’s Milestone Is the Market’s Most Dangerous Mirage

Feb 7, 2026·8m
Stocks·ai

AI Bubble Trouble: Why Wall Street’s $650 Billion Tech Splurge Could Unravel the S&P 500

Feb 7, 2026·8m
Stocks·pharma

Old Economy’s Revenge: Why Pharma’s Earnings Blitz Is the Real Rotation Story of 2026

Feb 7, 2026·8m
Stocks·xlk

XLK’s Dead Calm: Why Tech’s Flatline Masks a Volatility Time Bomb for US Equities

Feb 7, 2026·8m